Ochre Bio Company
Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.
Technology:
Biopharma, Biotechnology, Health Care, Therapeutics
Industry:
Early Drug Development, Preclinical Development, Regenerative medicine
Headquarters:
Oxford, Oxfordshire, United Kingdom
Founded Date:
2019-09-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
19
Total Funding:
39750000
Estimated Revenue:
Less than $1M
Last Funding Date:
2022-10-10
Last Funding Type:
Series A
Register and Claim Ownership